Johnson & Johnson MedTech’s launch of the KINCISE™ 2 Surgical Automated System represents a major step forward in orthopedic surgical technology, offering the only automated impactor approved for both knee and hip revision procedures. Building upon the functionality of its first-generation predecessor, KINCISE™ 2 integrates key innovations such as increased reverse energy and a new push-to-lock adaptor system. These upgrades are engineered to simplify surgical workflows, improve precision, and reduce time in the operating room—all while enabling greater control during demanding joint replacement procedures.

One of the most significant benefits of the KINCISE™ 2 System lies in its ability to reduce the physical toll on surgeons. Repetitive high-force mallet strikes are a known cause of occupational injuries in orthopedics, with over 90% of surgeons reporting musculoskeletal pain. By automating the impaction process, KINCISE™ 2 helps to minimize strain, particularly in complex revision surgeries where surgeon endurance and precision are crucial. Its ability to extract well-fixed acetabular cups further increases its value in difficult hip revision cases, making it a versatile and ergonomic solution.

As orthopedic surgeries grow in complexity and volume, tools that standardize procedures while enhancing outcomes are essential. KINCISE™ 2 addresses real-world surgical challenges with needs-driven innovation—improving efficiency, reducing surgeon fatigue, and delivering consistent, high-quality results. With its U.S. commercial release, this next-generation system not only elevates the surgical experience but also reinforces Johnson & Johnson MedTech’s commitment to advancing orthopedic care for both providers and patients.